Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AMONAFIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dorr, RT; Liddil, JD; Sami, SM; Remers, W; Hersh, EM; Alberts, DS
      Preclinical antitumor activity of the azonafide series of anthracene-basedDNA intercalators

      ANTI-CANCER DRUGS
    2. Villalona-Calero, MA; Eder, JP; Toppmeyer, DL; Allen, LF; Fram, R; Velagapudi, R; Myers, M; Amato, A; Kagen-Hallet, K; Razvillas, B; Kufe, DW; Von Hoff, DD; Rowinsky, EK
      Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    3. Costanza, ME; Weiss, RB; Henderson, IC; Norton, L; Berry, DA; Cirrincione, C; Winer, E; Wood, WC; Frei, E; McIntyre, OR; Schilsky, RL
      Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: Report of a randomized study - Cancer and leukemia group B 8642

      JOURNAL OF CLINICAL ONCOLOGY
    4. ASBURY R; BLESSING JA; REID GC; MCGUIRE WP
      A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ENDOMETRIAL CANCER - AGYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    5. ASBURY R; BLESSING JA; PODCZASKI E; BALL H
      A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    6. ASBURY R; BLESSING JA; BULLER R; MALFETANO JH; WALKER J; SEVIN BU
      AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    7. MAYR CA; SAMI SM; REMERS WA; DORR RT
      IDENTIFICATION AND CHARACTERIZATION OF IN-VITRO METABOLITES OF -1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONE (AZONAFIDE)

      Drug metabolism and disposition
    8. NITISS JL; ZHOU JF; ROSE A; HSIUNG YC; GALE KC; OSHEROFF N
      THE BIS(NAPHTHALIMIDE) DMP-840 CAUSES CYTOTOXICITY BY ITS ACTION AGAINST EUKARYOTIC TOPOISOMERASE-II

      Biochemistry
    9. STOCKERT JC; CANETE M; VILLANUEVA A; JUARRANZ A; TRIGOSO CI; BRANA MF
      FLUORESCENCE OF CHROMATIN DNA INDUCED BY ANTITUMORAL NAPHTHALIMIDES

      Zeitschrift fur Naturforschung. C, A journal of biosciences
    10. ASBURY R; BLESSING JA; LOOK KY; BULLER R; LUCCI JA
      A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    11. LEAF AN; NEUBERG D; SCHWARTZ EL; WADLER S; RITCH PS; DUTCHER JP; ADAMS GL
      AN ECOG PHASE-II STUDY OF AMONAFIDE IN UNRESECTABLE OR RECURRENT CARCINOMA OF THE HEAD AND NECK (PB390)

      Investigational new drugs
    12. BRANA MF; CASTELLANO JM; PERRON D; MAHER C; CONLON D; BOUSQUET PF; GEORGE J; QIAN XD; ROBINSON SP
      CHROMOPHORE-MODIFIED BIS-NAPHTHALIMIDES - SYNTHESIS AND ANTITUMOR-ACTIVITY OF BIS-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES

      Journal of medicinal chemistry
    13. WITTE RS; HSIEH P; ELSON P; OKEN MM; TRUMP DL
      A PHASE-II TRIAL OF AMONAFIDE, CARACEMIDE, AND HOMOHARRINGTONINE IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CANCER

      Investigational new drugs
    14. ROSEN F; VOKES EE; LAD T; KIES M; WADE J; KILTON LJ; BLOUGH R; FRENCH S; MULLANE M; BENSON AB
      PHASE-II STUDY OF AMONAFIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND THE NECK - AN ILLINOIS-CANCER-CENTER STUDY

      Investigational new drugs
    15. CHANG AY; TU ZN; SMITH JL; BONOMI P; SMITH TJ; WIERNIK PH; BLUM R
      PHASE-II TRIAL OF GALLIUM NITRATE, AMONAFIDE AND TENIPOSIDE IN METASTATIC NON-SMALL-CELL LUNG-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E2588)

      Investigational new drugs
    16. LEVITT R; BUCKNER JC; CASCINO TL; BURCH PA; MORTON RF; WESTBERG MW; GOLDBERG RM; GALLAGHER JG; OFALLON JR; SCHEITHAUER BW
      PHASE-II STUDY OF AMONAFIDE IN PATIENTS WITH RECURRENT GLIOMA

      Journal of neuro-oncology
    17. BOUSQUET PF; BRANA MF; CONLON D; FITZGERALD KM; PERRON D; COCCHIARO C; MILLER R; MORAN M; GEORGE J; QIAN XD; KEILHAUER G; ROMERDAHL CA
      PRECLINICAL EVALUATION OF LU-79553 - A NOVEL BIS-NAPHTHALIMIDE WITH POTENT ANTITUMOR-ACTIVITY

      Cancer research
    18. BRANA MF; CASTELLANO JM; MORAN M; EMLING F; KLUGE M; SCHLICK E; KLEBE G; WALKER N
      SYNTHESIS, STRUCTURE AND ANTITUMOR-ACTIVITY OF NEW BENZ[D,E]ISOQUINOLINE-1,3-DIONES

      Arzneimittel-Forschung
    19. VANWARMERDAM LJC; VERWEIJ J; ROSING H; SCHELLENS JHM; MAES RAA; BEIJNEN JH
      LIMITED SAMPLING MODELS FOR TOPOTECAN PHARMACOKINETICS

      Annals of oncology
    20. MARSHALL ME; BLUMENSTEIN B; CRAWFORD ED; THOMPSON IM; CRAIG JB; EISENBERGER M; AHMANN F
      PHASE-II TRIAL OF AMONAFIDE FOR THE TREATMENT OF ADVANCED, HORMONALLYREFRACTORY CARCINOMA OF THE PROSTATE - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    21. ASBURY RF; BLESSING JA; SOPER JT
      A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (SC NUMBER-308847) IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX

      American journal of clinical oncology
    22. MALVIYA VK; LIU PY; OTOOLE R; ALBERTS DS; SURWIT E; ROSENOFF S; WARD JH; YU A; OSULLIVAN J; CRAIG JB
      PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ADVANCED METASTATIC OR RECURRENT ENDOMETRIAL ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      American journal of clinical oncology
    23. MULLANE MR; SCHILSKY RL; CARROLL RB; WADE JL; KILTON LJ; BLOUGH RR; BAUMAN A; FRENCH SL; BENSON AB
      PHASE-II STUDY OF AMONAFIDE IN GASTRIC ADENOCARCINOMA - AN ILLINOIS-CANCER-CENTER TRIAL

      Investigational new drugs
    24. MICK R; RATAIN MJ
      BOOTSTRAP VALIDATION OF PHARMACODYNAMIC MODELS DEFINED VIA STEPWISE LINEAR-REGRESSION

      Clinical pharmacology and therapeutics
    25. CAMACHO MA; TORRES AI; GIL ME; OBREGON MM; RUZ V
      QUALITATIVE AND QUANTITATIVE-DETERMINATION OF 2 NEW ANTITUMOR AGENTS FROM 1-8 NAPHTHALIMIDES IN TABLETS - VALIDATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD

      Arzneimittel-Forschung
    26. CHEN SF; BEHRENS DL; BEHRENS CH; CZERNIAK PM; DEXTER DL; DUSAK BL; FREDERICKS JR; GALE KC; GROSS JL; JIANG JB; KIRSHENBAUM MR; MCRIPLEY RJ; PAPP LM; PATTEN AD; PERRELLA FW; SEITZ SP; STAFFORD MP; SUN JH; SUN T; WUONOLA MA; VONHOFF DD
      XB596, A PROMISING BIS-NAPHTHALIMIDE ANTICANCER AGENT

      Anti-cancer drugs
    27. MICK R; RATAIN MJ
      STATISTICAL APPROACHES TO PHARMACODYNAMIC MODELING - MOTIVATIONS, METHODS, AND MISPERCEPTIONS

      Cancer chemotherapy and pharmacology
    28. ASBURY RF; BLESSING JA; LOOK KY; CLARKEPEARSON D; HOMESLEY HD
      A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER

      American journal of clinical oncology
    29. CHERUBIM P; DEADY LW; DORKOS M; QUAZI NH; BAGULEY BC; DENNY WA
      SYNTHESIS AND BIOLOGICAL EVALUATION OF PHENANTHRENE-DERIVED CARBOXAMIDES AS CYTOTOXIC AGENTS

      Anti-cancer drug design
    30. BRANA MF; CASTELLANO JM; MORAN M; DEVEGA MJP; ROMERDAHL CR; QIAN XD; BOUSQUET P; EMLING F; SCHLICK E; KEILHAUER G
      BIS-NAPHTHALIMIDES - A NEW CLASS OF ANTITUMOR AGENTS

      Anti-cancer drug design
    31. LEICHMAN CG; TANGEN C; MACDONALD JS; LEIMERT T; FLEMING TR
      PHASE-II TRIAL OF AMONAFIDE IN ADVANCED PANCREAS CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    32. SLAVIK M; KOPECKY KJ; SONDAK V; CRAIG JB; SAMSON MK
      EVALUATION OF AMONAFIDE IN DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    33. POPLIN E; FLEMING T; MACDONALD JS; EISENBERG P; FISHER RI; CONRAD ME
      AMONAFIDE TREATMENT OF REFRACTORY ESOPHAGEAL CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    34. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
      A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP

      Cancer
    35. RATAIN MJ; MICK R; SCHILSKY RL; SIEGLER M
      STATISTICAL AND ETHICAL ISSUES IN THE DESIGN AND CONDUCT OF PHASE-I AND PHASE-II CLINICAL-TRIALS OF NEW ANTICANCER AGENTS

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 21:56:16